Natural Is Not Necessarily Better

Getty Images The benefits of breastfeeding are so well recognized that pointing out a flaw usually meets with considerable doubt, if not with outright hostility. Yet what holds true for other areas of physiology and medicine holds true here: What is "natural" is not necessarily flawless. Breast milk is a case in point. Maternal immunoglobulins and leukocytes transferred to the infant by colostrum or milk generally bolster the infant's poorly developed immune response.1 However, in some instan

Written byDorothea Zucker-Franklin
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The benefits of breastfeeding are so well recognized that pointing out a flaw usually meets with considerable doubt, if not with outright hostility. Yet what holds true for other areas of physiology and medicine holds true here: What is "natural" is not necessarily flawless. Breast milk is a case in point.

Maternal immunoglobulins and leukocytes transferred to the infant by colostrum or milk generally bolster the infant's poorly developed immune response.1 However, in some instances the wisdom of breastfeeding is questionable, as when mother and child are not Rh or ABO blood group compatible or when the mother carries a microorganism, such as the human T-cell lymphotropic virus Type I (HTLV-I). It seems appropriate to question whether the transfer of lymphocytes, especially allotypic lymphocytes, from mother to infant by breast milk, is wise.

Colostrum contains about 10,000 lymphocytes per mm; approximately 2,000 of those are T lymphocytes. Because newborns have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies